Literature DB >> 9196206

Descriptive profile of tuberculin skin testing programs and laboratory-acquired tuberculosis infections in public health laboratories.

A S Kao1, D A Ashford, M M McNeil, N G Warren, R C Good.   

Abstract

The increase in numbers of cases of tuberculosis in the United States has placed greater demands on mycobacteriology laboratory workers to produce rapid and accurate results. The greater number of specimens generated by the increased emphasis on detecting the disease has placed these workers at greater risk of laboratory-acquired infection. We surveyed 56 state and territorial public health laboratories to determine the status of existing tuberculin skin testing (TST) programs and to evaluate the frequency of probable laboratory-acquired tuberculosis for each responding mycobacteriology laboratory. Probable laboratory-acquired infections were determined by each laboratory's evaluation of occupational positions, duties, and employee histories and review of medical records. Two-step TST for new employees was routinely practiced in only 33% of responding laboratories, and mycobacteriology laboratorians were found to be most frequently screened when they were compared to employees of other departments. Of 49 (88%) responding laboratories, 13 reported that 21 employees were TST converters from 1990 to 1994. Seven of these 21 employees were documented to have laboratory-acquired infections based on evaluations by their respective laboratories. Based on Centers for Disease Control and Prevention guidelines, converters are categorized on the basis of both a change in the size of the zone of induration and the age of the person being tested. By the definitions in the guidelines, 14 mycobacteriologists were identified as recent converters, 7 of whom were > or = 35 years of age and 4 of whom were exposed in the laboratory within a 2-year period. Inadequate isolation procedures, the high volume of specimen handling, and faulty ventilation accounted for these laboratory-associated infections. These results suggest that more frequent periodic evaluations based on documented TST conversions for workers in mycobacterial laboratories should be performed, since this population is at increased risk of becoming infected with Mycobacterium tuberculosis. Although general assessments are necessary to accurately and effectively evaluate the risk of tuberculosis transmission, they are especially important for those working in high-risk areas within a public health laboratory.

Entities:  

Mesh:

Year:  1997        PMID: 9196206      PMCID: PMC229854          DOI: 10.1128/jcm.35.7.1847-1851.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Health of laboratory workers.

Authors:  J M Harrington
Journal:  Proc R Soc Med       Date:  1975-02

2.  Incidence of tuberculosis among workers in medical laboratories.

Authors:  D D REID
Journal:  Br Med J       Date:  1957-07-06

3.  High incidence of pulmonary tuberculosis in pathologists at Tokai University Hospital: an epidemiological study.

Authors:  M Sugita; Y Tsutsumi; M Suchi; H Kasuga
Journal:  Tokai J Exp Clin Med       Date:  1989-03

4.  Incidence of tuberculosis, hepatitis, brucellosis, and shigellosis in British medical laboratory workers.

Authors:  J M Harrington; H S Shannon
Journal:  Br Med J       Date:  1976-03-27

5.  Laboratory-acquired infections.

Authors:  S E SULKIN; R M PIKE
Journal:  J Am Med Assoc       Date:  1951-12-29

6.  Infections acquired in clinical laboratories in Utah.

Authors:  J T Jacobson; R B Orlob; J L Clayton
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

7.  Laboratory-acquired mycobacterial infection.

Authors:  H E Müller
Journal:  Lancet       Date:  1988-08-06       Impact factor: 79.321

8.  Association of Clinical Pathologists' surveys of infection in British clinical laboratories, 1970-1989.

Authors:  N R Grist; J A Emslie
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

9.  Increased rate of tuberculin skin test conversion among workers at a university hospital.

Authors:  J A Ramirez; P Anderson; S Herp; M J Raff
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

10.  Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients.

Authors:  C Beck-Sagué; S W Dooley; M D Hutton; J Otten; A Breeden; J T Crawford; A E Pitchenik; C Woodley; G Cauthen; W R Jarvis
Journal:  JAMA       Date:  1992-09-09       Impact factor: 56.272

View more
  7 in total

1.  Inactivation of cultured Mycobacterium tuberculosis organisms prior to DNA extraction.

Authors:  Zoheira Djelouagji; Michel Drancourt
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

Review 2.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

3.  Method for inactivating and fixing unstained smear preparations of mycobacterium tuberculosis for improved laboratory safety.

Authors:  Pamela Chedore; Cecelia Th'ng; Dennis H Nolan; George M Churchwell; David E Sieffert; Yvonne M Hale; Frances Jamieson
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Laboratory exposure to influenza A H2N2, Germany, 2004-2005.

Authors:  Annette Schrauder; Brunhilde Schweiger; Udo Buchholz; Walter Haas; Daniel Sagebiel; Adrienne Guignard; Wiebke Hellenbrand
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

5.  Viability testing of material derived from Mycobacterium tuberculosis prior to removal from a containment level-III laboratory as part of a Laboratory Risk Assessment Program.

Authors:  Kym S Blackwood; Tamara V Burdz; Christine Y Turenne; Meenu K Sharma; Amin M Kabani; Joyce N Wolfe
Journal:  BMC Infect Dis       Date:  2005-01-24       Impact factor: 3.090

Review 6.  Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.

Authors:  Ana Cláudia Coelho; Juan García Díez
Journal:  Front Bioeng Biotechnol       Date:  2015-04-28

7.  Biosafety and Proteome Profiles of Different Heat Inactivation Methods for Mycobacterium tuberculosis.

Authors:  Cheng-Hui Wang; Denise Utami Putri; Jau-Ching Lee; Chi-Chih Liao; Sung-Tzu Tsao; Ai-Lin Hsiao; Jhao-Hui Wu; Xiao-Wei Chen; Chih-Hsin Lee; I-Lin Tsai
Journal:  Microbiol Spectr       Date:  2021-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.